1. Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS). Issue 4 (April 2015) Authors: Bourlière, Marc; Bronowicki, Jean-Pierre; de Ledinghen, Victor; Hézode, Christophe; Zoulim, Fabien; Mathurin, Philippe; Tran, Albert; Larrey, Dominique G; Ratziu, Vlad; Alric, Laurent; Hyland, Robert H; Jiang, Deyuan; Doehle, Brian; Pang, Phillip S; Symonds, William T; Subramanian, G Mani; McHutc... Journal: Lancet infectious diseases Issue: Volume 15:Issue 4(2015:Apr.) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS). Issue 4 (April 2015) Authors: Bourlière, Marc; Bronowicki, Jean-Pierre; de Ledinghen, Victor; Hézode, Christophe; Zoulim, Fabien; Mathurin, Philippe; Tran, Albert; Larrey, Dominique G; Ratziu, Vlad; Alric, Laurent; Hyland, Robert H; Jiang, Deyuan; Doehle, Brian; Pang, Phillip S; Symonds, William T; Subramanian, G Mani; McHutc... Journal: Lancet infectious diseases Issue: Volume 15:Issue 4(2015:Apr.) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗